For the year ending 2025-12-31, HRGN has $2,677K in assets. $1,620K in debts. $1,352K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,352 | |||
| Accounts receivable | 16 | |||
| Inventory | 16 | |||
| Prepaid research and development | 18 | |||
| Prepaid expenses and other current assets | 427 | |||
| Total current assets | 1,829 | |||
| Total property, plant and equipment | 1,487 | |||
| Less accumulated depreciation | 1,481 | |||
| Property, plant and equipment, net | 6 | |||
| Right-of-use assets, net | 195 | |||
| Long-term prepaid contracts | 647 | |||
| Total assets | 2,677 | |||
| Accounts payable | 454 | |||
| Accrued and other current liabilities | 532 | |||
| Deferred revenue | 252 | |||
| Insurance premium financing payable | 183 | |||
| Operating lease liability | 113 | |||
| Total current liabilities | 1,534 | |||
| Operating lease liability, net of current portion | 86 | |||
| Total liabilities | 1,620 | |||
| Common stock, par value 0.01 per share, 60,000,000 shares authorized 17,580,744 and 15,918,979 issued and outstanding at december 31, 2025 and 2024, respectively | 176 | |||
| Additional paid-in capital | 107,450 | |||
| Accumulated deficit | -106,557 | |||
| Accumulated other comprehensive loss | -12 | |||
| Total stockholders equity | 1,057 | |||
| Total liabilities and stockholders equity | 2,677 | |||
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)